AD

Amarendra Deka

Active Director Director DIN 07185476
DIN 07185476 First appointment Aug 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2015
Shareholding value •••• Premium profile

About Amarendra Deka

Data last updated:

Amarendra Deka is a Director at Vacslife Pharmaceuticals Private Limited (since 2015). The company operates in Pharma. Vacslife Pharmaceuticals Private Limited reported revenue of ₹24.4 Lakh (FY 2021).

DIN 07185476
Primary Designation Director
Industry Pharma
First Appointment 05 Aug 2015
Oldest Company Age 11 yrs
Largest company Vacslife Pharmaceuticals Private Limited · ₹24.4 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Aug 20152015₹24.4 Lakh (FY 2021)Active

Board colleagues of Amarendra Deka

Directorship timeline

Open interactive timeline →
Vacslife Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amarendra Deka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amarendra Deka

Amarendra Deka currently holds 1 directorship: Vacslife Pharmaceuticals Private Limited (Director, since 05 Aug 2015, revenue ₹24.4 Lakh (FY 2021)).

Amarendra Deka was first appointed on 05 Aug 2015 as Director at Vacslife Pharmaceuticals Private Limited.

The current boards of Amarendra Deka's companies include Simanta Pradeep Saikia (Vacslife Pharmaceuticals Private Limited), Valensha Surong (Vacslife Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available